Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1011115
Abstract: Ulcerative colitis (UC) is a chronic relapsing disease featuring aberrant accumulation of neutrophils in colonic mucosa and the luminal space. Although significant advances in UC therapy have been made with the development of novel biologics… read more here.
Keywords: colonic mucosa; reducing neutrophil; colitis reducing; atovaquone ... See more keywords